Encrypted login | home

Program Information

Clinical Implementation of HDR Brachytherapy


H Al-Hallaq

J Esthappan

J Prisciandaro




H Al-Hallaq1*, J Esthappan2*, J Prisciandaro3*, (1) The University of Chicago, Chicago, IL, (2) Washington University School of Medicine, St. Louis, MO, (3) University of Michigan, Ann Arbor, MI

Presentations

TU-C-201-0 (Tuesday, July 14, 2015) 10:15 AM - 11:15 AM Room: 201


Recent use of HDR has increased while planning has become more complex often necessitating 3D image-based planning. While many guidelines for the use of HDR exist, they have not kept pace with the increased complexity of 3D image-based planning. Furthermore, no comprehensive document exists to describe the wide variety of current HDR clinical indications. This educational session aims to summarize existing national and international guidelines for the safe implementation of an HDR program. A summary of HDR afterloaders available on the market and their existing applicators will be provided, with guidance on how to select the best fit for each institution’s needs. Finally, the use of checklists will be discussed as a means to implement a safe and efficient HDR program and as a method by which to verify the quality of an existing HDR program. This session will provide the perspective of expert HDR physicists as well as the perspective of a new HDR user.

Learning Objectives:
1. Summarize national and international safety and staffing guidelines for HDR implementation
2. Discuss the process of afterloader and applicator selection for gynecologic, prostate, breast, interstitial, surface treatments
3. Learn about the use of an audit checklist tool to measure of quality control of a new or existing HDR program
4. Describe the evolving use of checklists within an HDR program



Contact Email: